Sumitomo Mitsui Trust Holdings, Inc. Madrigal Pharmaceuticals, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $145 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024
SELL
$171.37 - $283.23 $268,365 - $443,538
-1,566 Reduced 65.11%
839 $224,000
Q4 2023

Jan 30, 2024
BUY
$120.4 - $237.13 $27,330 - $53,828
227 Added 10.42%
2,405 $556,000
Q3 2023

Oct 30, 2023
BUY
$146.04 - $225.78 $318,075 - $491,748
2,178 New
2,178 $318,000

Others Institutions Holding MDGL

# of Institutions
338
Shares Held
22.7M
Call Options Held
757K
Put Options Held
960K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.77B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email